首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
【2h】

Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.

机译:乳腺癌细胞中Cyclin D1的诱导缩短了G1足以使滞留在G1中的细胞完成细胞周期。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The sequential transcriptional activation of cyclins, the regulatory subunits of cell-cycle-specific kinases, is thought to regulate progress through the cell cycle. Cyclins are therefore potential oncogenes, and cyclin D1 overexpression and/or amplification at its genomic locus, 11q13, are common features of several human cancers. Induction of cyclin D1 is an early response to mitogenic stimulation in several cell types, but the consequences of altered expression of this gene in human cells of epithelial origin remain undefined. We assessed the effects of alterations of cyclin D1 expression in human breast cancer cells by generating T-47D cells expressing human cyclin D1 under the control of a zinc-responsive metallothionein promoter. In cycling cells induction of cyclin D1 after zinc treatment resulted in an increase in the number of cells progressing through G1 and in the rate of transition from G1 to S phase, indicating that cyclin D1 is rate-limiting for progress through G1 phase. In cells arrested in early G1 phase after growth factor deprivation, zinc induction of cyclin D1 was sufficient for completion of the cell cycle, a process requiring growth factor stimulation in control cells. These data demonstrate a critical role for cyclin D1 in human breast cancer cell-cycle control and suggest that deregulated expression of cyclin D1 is likely to reduce dependence on normal physiological growth stimuli, thereby providing a growth advantage to tumor cells and a potential mechanism of resistance to endocrine therapy.
机译:细胞周期蛋白,细胞周期特异性激酶的调节亚基,细胞周期蛋白的顺序转录激活被认为可以调节整个细胞周期的进程。因此,细胞周期蛋白是潜在的癌基因,而细胞周期蛋白D1在其基因组位点11q13的过表达和/或扩增是几种人类癌症的共同特征。在几种细胞类型中,细胞周期蛋白D1的诱导是对促有丝分裂刺激的早期反应,但是该基因在上皮来源的人细胞中表达改变的后果仍然不确定。我们通过在锌反应性金属硫蛋白启动子的控制下生成表达人细胞周期蛋白D1的T-47D细胞来评估人乳腺癌细胞中细胞周期蛋白D1表达改变的影响。在循环细胞中,锌处理后诱导细胞周期蛋白D1导致通过G1进行的细胞数量增加,并且细胞从G1过渡到S期的速率增加,这表明细胞周期蛋白D1限制了通过G1相进行的速率。在剥夺生长因子后在早期G1期停滞的细胞中,细胞周期蛋白D1的锌诱导足以完成细胞周期,这一过程需要在对照细胞中刺激生长因子。这些数据证明了细胞周期蛋白D1在人类乳腺癌细胞周期控制中的关键作用,并表明细胞周期蛋白D1的表达失调可能会减少对正常生理生长刺激的依赖性,从而为肿瘤细胞提供生长优势和潜在的耐药机制进行内分泌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号